← Eichor
Study identifier: NCT04720456 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SHAPE of Portal Hypertension in Children

Condition: Hypertension, Portal  ·  Sponsor: Thomas Jefferson University

PhasePhase 2
Planned participants120
Who can joinAll sexes, 6 Years to 21 Years
Healthy volunteersNo

About this study

Early diagnosis of portal hypertension is difficult as symptoms rarely manifest until the later stages of liver disease. Both cirrhotic and non-cirrhotic portal hypertension can result in life-threatening complications, the most frequent of which is bleeding from esophageal varices. In children, variceal bleeds are associated with mortality rates of 1-3 %, while life-threatening complications have been reported in up to 20 % of children with cirrhosis. Despite the high incidence of portal hypertension in children with liver disease, a noninvasive modality to monitor disease progression and risk of complications is currently lacking. Hence, this trial will investigate the safety and efficacy of subharmonic aided pressure estimation (SHAPE) as a noninvasive ultrasound technique for diagnosing portal hypertension in children.

This description comes directly from the study's public registry record.

Talk to the study team

Morgan L Gabbert, MA  ·  267-426-0820  ·  gabbertm@email.chop.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04720456